United States· US:0115-1234_a8dc6624-df1e-4e5a-b445-9541658e3430

Oxymorphone hydrochloride

A oxymorphone product containing oxymorphone hydrochloride, registered in United States by Amneal Pharmaceuticals of New York LLC.

ATC N02AA11US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxymorphone hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: OXYMORPHONE HYDROCHLORIDE
Manufacturer: Amneal Pharmaceuticals of New York LLC
Country: United States (US)
ATC code: N02AA11
ATC class: Oxymorphone
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 8

ndc11
0115123401
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-01)
ndc11
0115123403
1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-03)
ndc11
0115123408
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-08)
ndc11
0115123413
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1234-13)
ndc11
0115-1234-01
ndc11
0115-1234-03
ndc11
0115-1234-08
ndc11
0115-1234-13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

110 interactions on record for oxymorphone.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxymorphone against other medicines How interaction checks work

Oxymorphone · interactions on record

110 records

14 severe
96 moderate

Most severe, free to view

AlvimopanA06AH02severe
ChlorphenesinD01AE07severe
ChlorphenesinG01AX21severe
ProcarbazineL01XB01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N02AA11

Oxymorphone, as other registers publish it.

All oxymorphone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5854f6fd-e506-4919-aa86-e7f7f1e6f3fd
GET /v1/drugs/5854f6fd-e506-4919-aa86-e7f7f1e6f3fd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "40",
  "substance": "OXYMORPHONE HYDROCHLORIDE",
  "productndc": "0115-1234",
  "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
  "dea_schedule": "CII",
  "strength_unit": "mg/1",
  "application_number": "ANDA079087",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about oxymorphone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console